These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6453178)
21. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells. OKunewick JP; Buffo MJ; Kociban DL Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836 [TBL] [Abstract][Full Text] [Related]
22. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340 [TBL] [Abstract][Full Text] [Related]
23. [Effect of cyclophosphamide on the bone marrow hematopoiesis in the mouse]. Xie RF Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):435-7. PubMed ID: 3836845 [TBL] [Abstract][Full Text] [Related]
24. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1. Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812 [TBL] [Abstract][Full Text] [Related]
25. Effect of myleran on murine hemopoiesis. II. Direct and host-mediated action on proliferative capacity and differentiation bias of spleen colony forming units (CFU-S). Delmonte L Cell Tissue Kinet; 1978 Jul; 11(4):359-67. PubMed ID: 688327 [No Abstract] [Full Text] [Related]
26. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103 [TBL] [Abstract][Full Text] [Related]
27. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906 [TBL] [Abstract][Full Text] [Related]
28. Influence of IL-10 on murine CFU-pre-B formation. Fine JS; Macosko HD; Grace MJ; Narula SK Exp Hematol; 1994 Nov; 22(12):1188-96. PubMed ID: 7925782 [TBL] [Abstract][Full Text] [Related]
29. The hematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene. Seidel HJ; Barthel E; Zinser D Exp Hematol; 1989 Mar; 17(3):300-3. PubMed ID: 2917624 [TBL] [Abstract][Full Text] [Related]
30. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia. Kubota K; Preisler HD; Costanzo C; Miura Y Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066 [TBL] [Abstract][Full Text] [Related]
31. In vitro effect of captopril and three captopril metabolites on neutrophilic progenitor cells from normal mice and mice given busulfan. Boyd RL; Erslev AJ; Caro J J Lab Clin Med; 1984 Jul; 104(1):44-50. PubMed ID: 6376669 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan. Patchen ML; Vaudrain T; Correira H; Martin T; Reese D Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381 [TBL] [Abstract][Full Text] [Related]
33. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis. Scheding S; Media JE; Nakeff A Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060 [TBL] [Abstract][Full Text] [Related]
34. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781 [TBL] [Abstract][Full Text] [Related]
35. Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells. Huybrechts M; Symann M; Trouet A Cancer Res; 1979 Sep; 39(9):3738-43. PubMed ID: 476697 [TBL] [Abstract][Full Text] [Related]
36. c-kitLian Z; Feng B; Sugiura K; Inaba M; Yu C; Jin T; Fan T; Cui Y; Yasumizu R; Toki J; Adachi Y; Hisha H; Ikehara S Stem Cells; 1999; 17(1):39-44. PubMed ID: 10215400 [TBL] [Abstract][Full Text] [Related]
37. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM; Gulati SC Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [TBL] [Abstract][Full Text] [Related]
38. Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF. Kovacs CJ; Evans MJ; Roberts C; Harrell J; Abernathy R; Gooya J; Johnke RM Exp Hematol; 1995 Aug; 23(9):1016-23. PubMed ID: 7635181 [TBL] [Abstract][Full Text] [Related]
39. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression. Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845 [TBL] [Abstract][Full Text] [Related]
40. Modulatory effects of Schistosoma mansoni infection on bone marrow granulopoietic and erythropoietic activity in mice. Kamal KA; Fata JS; Kilroy S; Skelly RR; Ansari AA Ann Clin Lab Sci; 1989; 19(1):56-64. PubMed ID: 2492789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]